NAV Trademark

Trademark Overview

On Friday, May 6, 2011, a trademark application was filed for NAV with the United States Patent and Trademark Office. The USPTO has given the NAV trademark a serial number of 85314838. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Wednesday, March 11, 2020. This trademark is owned by Regenx Biosciences, LLC. The NAV trademark is filed in the Pharmaceutical Products category with the following description:

Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic pharmaceutical compositions that include recombinant adenoassociated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy; pharmaceutical preparations containing adeno-associated virus (AAV) vectors and nucleic acid for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, neurodegenerative disorders, metabolic and hematologic disorders, cardiovascular, oncologic and ocular diseases
nav

General Information

Serial Number85314838
Word MarkNAV
Filing DateFriday, May 6, 2011
Status710 - CANCELLED - SECTION 8
Status DateWednesday, March 11, 2020
Registration Number4384442
Registration DateTuesday, August 13, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements

Goods and ServicesClinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic pharmaceutical compositions that include recombinant adenoassociated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy; pharmaceutical preparations containing adeno-associated virus (AAV) vectors and nucleic acid for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders, namely, neurodegenerative disorders, metabolic and hematologic disorders, cardiovascular, oncologic and ocular diseases
Pseudo MarkNUCLEIC ACID VECTORS ; NUCLEIC ACID VIRUS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateSunday, May 1, 2011
First Use In Commerce DateSunday, May 1, 2011

Trademark Owner History

Party NameREGENXBIO INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameRegenx Biosciences, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20006
Party NameRegenx Biosciences, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20006
Party NameRegenx Biosciences, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWashington, DC 20006

Trademark Events

Event DateEvent Description
Monday, June 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 12, 2020NOTICE OF CANCELLATION SEC. 8 EMAILED
Wednesday, March 11, 2020CANCELLED SEC. 8 (6-YR)
Wednesday, September 4, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, August 29, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 7, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, August 13, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 25, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 7, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 26, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 26, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 14, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, July 25, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 10, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, July 8, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 24, 2013STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 21, 2013USE AMENDMENT FILED
Wednesday, June 19, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 21, 2013TEAS STATEMENT OF USE RECEIVED
Thursday, January 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2013EXTENSION 1 GRANTED
Tuesday, January 8, 2013EXTENSION 1 FILED
Tuesday, January 8, 2013TEAS EXTENSION RECEIVED
Tuesday, July 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 5, 2012ASSIGNED TO LIE
Saturday, March 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 25, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 24, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 24, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2011NON-FINAL ACTION WRITTEN
Friday, August 19, 2011ASSIGNED TO EXAMINER
Friday, May 13, 2011NOTICE OF PSEUDO MARK MAILED
Thursday, May 12, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 10, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapy disorders gene pharmaceutical diseases vectors therapeutic preparations biological genes